Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Cytochrome P450c17 catalyzes the 17alpha-hydroxylase activity required for glucocorticoid synthesis and the 17,20 lyase activity required for sex steroid synthesis. Most P450 enzymes have fixed ratios of their various activities, but the ratio of these two activities of P450c17 is regulated post-translationally. We have shown that serine phosphorylation of P450c17 and the allosteric action of cytochrome b5 increase 17,20 lyase activity, but it has not been apparent whether these two post-translational mechanisms interact. Using purified enzyme systems, we now show that the actions of cytochrome b5 are independent of the state of P450c17 phosphorylation. Suppressing cytochrome b5 expression in human adrenal NCI-H295A cells by >85% with RNA interference had no effect on 17alpha-hydroxylase activity but reduced 17,20 lyase activity by 30%. Increasing P450c17 phosphorylation could compensate for this reduced activity. When expressed in bacteria, human P450c17 required either cytochrome b5 or phosphorylation for 17,20 lyase activity. The combination of cytochrome b5 and phosphorylation was not additive. Cytochrome b5 and phosphorylation enhance 17,20 lyase activity independently of each other, probably by increasing the interaction between P450c17 and NADPH-cytochrome P450 oxidoreductase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 17,20-lyase activity is also favored by the phosphorylation of serine residues on P450c17 by a cAMP-dependent protein kinase (287-290).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [289]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mechanism would account for b5 having no effect on the Km of P450c17, while increasing the Vmax of the 17,20-lyase reaction”
From Steroidogenic electron-transfer factors and their diseases (2021) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Substantial evidence indicates that b5 enhances the interaction of P450c17 and POR, promoting more efficient electron transfer”
From Steroidogenic electron-transfer factors and their diseases (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Note that the heme group in cytochrome b 5 faces out of the plane of the page and does not contact either the POR or P450c17.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [289]
Experimental — accuracy not yet measuredIn the citing paper
“Cytochrome b 5 (b5) is familiar to endocrinologists for promoting the 17,20-lyase activity of P450c17 (CYP17A1), thus regulating the synthesis of androgen precursors ( 8 , 9 );”
From Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Miroux, B., & Walker, J. E. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0399 · Cited by 1,959
Molecular biology of steroid hormone synthesis
MILLER, W. L. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-295 · Cited by 1,397
Self-citationORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
Lu, A. Y. H., Junk, K. W., & Coon, M. J. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83427-5 · Cited by 577
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationGazdar, A. F., Oie, H. K., Shackleton, C. H. L., Chen, T. R., Triche, T. J., Myers, C. E., Chrousos, G. P., Brennan, M. F., Stein, C. A., & Rocca, R. V. L. (1990) · PubMed · Cited by 523
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citation
Research works printed but not linked: 8
- Auchus, 1999, Mol. Endocrinol., 13, 1169
- Lin, 1993, Endocrinology., 132, 2498, 10.1210/endo.132.6.8504753 · doi:10.1210/endo.132.6.8504753 · Paper page
- Rodriguez, 1997, J. Clin. Endocrinol. Metab., 82, 365
- Gazdar, 1990, Cancer Res., 50, 5488
- Staels, 1993, Mol. Endocrinol., 7, 423
- Mapes, 2002, Endocrinology., 143, 1451, 10.1210/endo.143.4.8718 · doi:10.1210/endo.143.4.8718 · Paper page
- Mapes, 1999, J. Clin. Endocrinol. Metab., 84, 3382
- Sakai, 1993, J. Clin. Endocrinol. Metab., 76, 1286
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationCytochromes P450 as versatile biocatalysts
Bernhardt, R. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.01.026 · Cited by 886
Human cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
Self-citationInsulin and hyperandrogenism in women with polycystic ovary syndrome
Baptiste, C. G., Battista, M.-C., Trottier, A., & Baillargeon, J.-P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.010 · Cited by 355
Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.-C., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 357
Minireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Self-citationPolycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Self-citationSteroidogenesis: Unanswered Questions
Miller, W. L. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.09.002 · Cited by 226
Self-citationKamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191
“The activity of the 17,20 lyase reaction of CYP17A1 for the classic pathways is enhanced by the expression of cytochrome b5 at the onset of adrenarche (1, 28).”
BackgroundZhou, L.-Y., Wang, D.-S., Kobayashi, T., Yano, A., Paul-Prasanth, B., Suzuki, A., Sakai, F., & Nagahama, Y. (2007) · Endocrinology · doi:10.1210/en.2007-0487 · Cited by 165
Androgen excess: Investigations and management
Lizneva, D., Gavrilova-Jordan, L. P., Walker, W., & Azziz, R. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.05.003 · Cited by 176
“Furthermore, the zonae reticularis has abundant cytochrome b5, which fosters the production of androgens by P450c17 [3].”
BackgroundInfluentialGuengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 214
The syndrome of 17,20 lyase deficiency
Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2161 · Cited by 143
Self-citationMECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Self-citationBremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 151
Self-citationAndrogen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127
“also increases 17,20 lyase activity [82–84], but the kinase has not been identified [85], hence its role in adrenarche remains uncertain.”
BackgroundSelf-citationA review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)
Akhtar, M., Wright, J. N., & Lee-Robichaud, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.003 · Cited by 131
Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
“17,20-Lyase activity can be enhanced independently of 17-hydroxylase by phosphorylation of serine and threonine residues of P450c17 (23).”
BackgroundHuman steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins
Andersen, C. Y., & Ezcurra, D. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-128 · Cited by 108
“Increasing the ratio of POR to CYP17 also increases the ratio of lyase to hydroxylase activity [11].”
BackgroundInfluentialCytochrome b5 modulation of 17α hydroxylase and 17–20 lyase (CYP17) activities in steroidogenesis
Akhtar, M. K., Kelly, S. L., & Kaderbhai, M. A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06375 · Cited by 120
“Recently, the enhancement of 17,20 lyase by serine phosphorylation and cytochrome b5 has been shown to occur independently of each other (Pandey & Miller 2005).”
BackgroundHershkovitz, E., Parvari, R., Wudy, S. A., Hartmann, M. F., Gomes, L. G., Loewental, N., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0051 · Cited by 95
Self-citationExtraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1174 · Cited by 91
“This construct was expressed in Escherichia coli C41(DE3)pLysS, and bacterial membranes were prepared as described (21).”
MethodSelf-citationVilleneuve, D. L., Blake, L. S., Brodin, J. D., Greene, K. J., Knoebl, I., Miracle, A. L., Martinović‐Weigelt, D., & Ankley, G. T. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm124 · Cited by 103
“Since cyt b5 is thought to enhance the lyase activity of CYP17, increased expression of cyt b5 could also be viewed as offsetting the direct effects of KTC on androgen synthesis (Fig. 1; Akhtar et al., 2005; Miller, 2005; Pandy and Miller, 2005).”
BackgroundAdrenal Androgens in Humans and Nonhuman Primates: Production, Zonation and Regulation
Nguyen, A. D., & Conley, A. J. (2008) · Endocrine Development · doi:10.1159/000134765 · Cited by 90
Clinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Self-citationAbbott, D. H., Zhou, R., Bird, I. M., Dumesic, D. A., & Conley, A. J. (2008) · Endocrine Development · doi:10.1159/000134831 · Cited by 81
Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway
Castaño, P. R., Parween, S., & Pandey, A. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184606 · Cited by 72
“Steroid metabolism by NCI-H295R cells has been studied in our laboratory for many years and culture conditions and passage numbers (kept below 30) adhered to previously established protocols [40,41,55,56,89,90].”
BackgroundMethodInfluentialSelf-citationTee, M. K., & Miller, W. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.460048 · Cited by 69
“Bacterial Expression of P450c17 and POR—”
BackgroundInfluentialSelf-citationTang, J., Yu, C., Williams, S. R., Springman, E. B., Jeffery, D. A., Sprengeler, P. A., Estevez, A., Sampang, J., Shrader, W. D., Spencer, J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506766200 · Cited by 69
Naffin-Olivos, J. L., & Auchus, R. J. (2006) · Biochemistry · doi:10.1021/bi051623y · Cited by 66
Active site proton delivery and the lyase activity of human CYP17A1
Khatri, Y., Gregory, M. C., Grinkova, Y. V., Denisov, I. G., & Sligar, S. G. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.094 · Cited by 64
Chauvigné, F., Plummer, S. M., Lesné, L., Cravedi, J., Dejucq‐Rainsford, N., Fostier, A., & Jégou, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027172 · Cited by 67
“GPX1 and GSTA are essential for activation of the 17a-hydroxylase and 17,20 lyase activities of the enzyme through electrostatic interactions with their cofactors, principally cytochrome b5 and P450 oxidoreductase (POR) [39].”
BackgroundThe interplay between bioactive sphingolipids and steroid hormones
Lucki, N. C., & Sewer, M. B. (2010) · Steroids · doi:10.1016/j.steroids.2010.01.020 · Cited by 67
“For example, zone-specific expression of CYP17 [9] and cytochrome b5 [36-40] allow for glucocorticoid production in the zona fasciculata and androgen synthesis in the zona reticularis, whereas, the absence of CYP17 in the zona glomerulosa allows for mineralocorticoid secretion.”
Villeneuve, D. L., Blake, L. S., Brodin, J. D., Cavallin, J. E., Durhan, E. J., Jensen, K. M., Kahl, M. D., Makynen, E. A., Martinović‐Weigelt, D., Mueller, N. D., et al. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn073 · Cited by 67
“Published by Oxford University Press 2008. stages of germ cell development versus progestin production to support final germ cell maturation (Miller, 1988, 2005; Pandey and Miller, 2005; Patiño et al., 2001).”
BackgroundFlück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.035 · Cited by 59
Self-citationNonhuman primates as models for human adrenal androgen production: Function and dysfunction
Abbott, D. H., & Bird, I. M. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9099-8 · Cited by 61
“Such altered CYP17 function would enhance 17,20 lyase activity by increasing the affinity of CYP17 for its electron donor, P450 oxidoreductase [63].”
BackgroundMalíková, J., Brixius‐Anderko, S., Udhane, S. S., Parween, S., Dick, B., Bernhardt, R., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.09.007 · Cited by 65
Self-citationSalvador, J. A. R., Pinto, R. M. A., & Silvestre, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.006 · Cited by 82
“b5) [101–104], the phosphorylation f serine/threonine residues [101,105–107], and single amino acid utations [108–111].”
BackgroundSamandari, E., Kempná, P., Nuoffer, J., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0166 · Cited by 67
P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57
Self-citationTee, M. K., Dong, Q., & Miller, W. L. (2008) · Endocrinology · doi:10.1210/en.2007-1527 · Cited by 55
“NCI-H295 cells, derived from a human adrenocortical carcinoma (44), express P450c17, catalyze 17 -hydroxylase and 17,20 lyase activities (45, 46), and can phosphorylate P450c17 in a fashion that maximizes 17,20 lyase activity (29, 51).”
BackgroundSelf-citationFlück, C. E., Nicolo, C., & Pandey, A. V. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00520.x · Cited by 55
Self-citationGenetic variation in human P450 oxidoreductase
Miller, W. L., Huang, N., Agrawal, V., & Giacomini, K. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.017 · Cited by 54
“…. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183 (for review see Miller, 2005).”
Self-citationLundqvist, J., Norlin, M., & Wikvall, K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.009 · Cited by 61
Steroid Hydroxylation: Microbial Steroid Biotransformations Using Cytochrome P450 Enzymes
Bureik, M., & Bernhardt, R. (2007) · Wiley eBooks · doi:10.1002/9783527611522.ch6 · Cited by 54
Bhatt, M. R., Khatri, Y., Rodgers, R. J., & Martin, L. L. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.033 · Cited by 63
The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0304 · Cited by 52
Self-citationInterleukins 1α and 1β as regulators of steroidogenesis in human NCI-H295R adrenocortical cells
Tkachenko, I. V., Jääskeläinen, T., Jääskeläinen, J., Palvimo, J. J., & Voutilainen, R. (2011) · Steroids · doi:10.1016/j.steroids.2011.04.018 · Cited by 52
The post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“The interaction of P450c17 and POR is facilitated by the allosteric action of cytochrome b5, and by the serine phosphorylation of P450c17.”
BackgroundSelf-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Self-citationRestoration of mutant cytochrome P450 reductase activity by external flavin
Nicolo, C., Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.024 · Cited by 50
Self-citationVasotocin and Mesotocin Stimulate the Biosynthesis of Neurosteroids in the Frog Brain
Do-Rego, J.-L., Acharjee, S., Seong, J. Y., Galas, L., Alexandre, D., Bizet, P., Burlet, A., Kwon, H. B., Luu-The, V., Pelletier, G., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4469-05.2006 · Cited by 48
“Consistent with this notion, it is now established that phosphorylation of Ser 106 and Thr 112 residues in human P450C17 stimulates the activity of the enzyme (Lin et al., 1993; Zhang et al., 1995; Miller et al., 1997; Pandey and Miller, 2005).”
Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis
Udhane, S. S., Dick, B., Hu, Q., Hartmann, R. W., & Pandey, A. V. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.019 · Cited by 46
Self-citationFernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 49
“coli expression system and purified for enzyme kinetic assays [15,17,18,62].”
MethodSelf-citationA Rational Basis for Therapy in the Sick Postpartum Cow
Frazer, G. S. (2005) · Veterinary Clinics of North America Food Animal Practice · doi:10.1016/j.cvfa.2005.03.005 · Cited by 46
“The PGE2 acts by an autocrine/paracrine route to cause upregulation of the microsomal cytochrome P450 enzyme system (hydroxylase, lyase, and aromatase) in the placenta [5–8].”
BackgroundSwart, A. C., Storbeck, K., & Swart, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.014 · Cited by 45
Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677294 · Cited by 47
“This idea is also consistent with previous proposals for a stronger electron transfer complex during the b5-modulated lyase reaction (14) and enhanced lyase activity observed in phosphorylated CYP17A1 (proposed to enhance its interaction with CPR) (57).”
ResultSteroidogenic Capacity of Residual Ovarian Tissue in 4-Vinylcyclohexene Diepoxide-Treated Mice1
Rivera, Z., Christian, P. J., Marion, S. L., Brooks, H. L., & Hoyer, P. B. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.070359 · Cited by 47
“Specifically, it has been shown that 17,20-lyase activity of CYP17A1, which is responsible for the production of DHEA and androstenedione, is favorably regulated by serine phosphorylation in cultured human adrenocortical carcinoma cells [47].”
do Rego, J. L., Vaudry, D., & Vaudry, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120473 · Cited by 54
Huang, N., Dardis, A., & Miller, W. L. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0411 · Cited by 42
Self-citationA novel communication role for CYP17A1 in the progression of castration‐resistant prostate cancer
Locke, J. A., Fazli, L., Adomat, H. H., Smyl, J., Weins, K., Lubik, A. A., Hales, D. B., Nelson, C. C., Gleave, M. E., & Guns, E. T. (2009) · The Prostate · doi:10.1002/pros.20940 · Cited by 45
“Based on kinetic studies the lyase activity of CYP17A1 has been shown to be ratelimiting in steroid synthesis [3,7] and is highly dependent on the interactions between the substrate and CYP17A1 protein in its binding conformation [8–11].”
BackgroundPolycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance
Hernández-Jiménez, J. L., Barrera, D., Espinoza‐Simón, E., González, J., Ortiz-Hernández, R., Escobar, M. L., Echeverría, O. M., & Torres‐Ramírez, N. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2003326 · Cited by 52
“Treatment with metformin can alleviate these symptoms through several routes: 1) reduction of reactive oxygen species (ROS) and inhibition of oxidative stress (OS), 2) inhibition of the activity of NADPH oxidase and increase in the expression and activity of antioxidant enzymes, 3) possibly, the increase in the produc…”
BackgroundInfluentialImpact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase
Flück, C. E., & Pandey, A. V. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.031 · Cited by 43
Self-citationP450 Enzymes in Steroid Processing
Auchus, R. J., & Miller, W. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_12 · Cited by 44
Self-citationNguyen, A. D., Mapes, S. M., Corbin, C. J., & Conley, A. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0337 · Cited by 38
Cytochrome b5: Novel roles in steroidogenesis
Storbeck, K., Swart, A. C., Goosen, P., & Swart, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.11.020 · Cited by 45
“1 and consists of five exons that encode for the 146 amino acid mitochondrial membrane-bound form (Giordano and Steggles 1991; Giordano et al. 1993; Pandey and Miller 2005; Giordano and Steggles 1993; Cristiano et al.”
InfluentialPattison, J. C., Saltzman, W., Abbott, D. H., Hogan, B. K., Nguyen, A. D., Husen, B., Einspanier, A., Conley, A. J., & Bird, I. M. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.023 · Cited by 40
Pandey, A. V., Flück, C. E., & Mullis, P. E. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.072 · Cited by 36
Self-citationUpdate on Adrenarche—Still a Mystery
Augsburger, P., Liimatta, J., & Flück, C. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae008 · Cited by 48
Sivoňová, M. K., Jurečeková, J., Tatarková, Z., Kaplán, P., Lichardusová, L., & Hatok, J. (2017) · General Physiology and Biophysics · doi:10.4149/gpb_2017024 · Cited by 41
Kempná, P., Hirsch, A., Hofer, G., Mullis, P. E., & Flück, C. E. (2010) · Endocrinology · doi:10.1210/en.2010-0093 · Cited by 36
“To estimate the P450c17 content in microsomes isolated from H295R cells, Western blot analysis was performed with anti-P450c17 antibody loading several samples of 40 g of microsomal protein and 3, 10, 30, and 100 ng recombinant P450c17 protein (25) as standards for quantification on a SDS-PAGE before blotting and deve…”
MethodCytochrome b5 modulates multiple reactions in steroidogenesis by diverse mechanisms
Storbeck, K., Swart, A. C., Fox, C.-L., & Swart, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.024 · Cited by 36
Steroidogenic Enzymes in Leydig Cells
Payne, A. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-453-7_10 · Cited by 39
Nguyen, A. D., Corbin, C. J., Pattison, J. C., Bird, I. M., & Conley, A. J. (2008) · Endocrinology · doi:10.1210/en.2008-1303 · Cited by 36
Storbeck, K., Kolar, N. W., Stander, M. A., Swart, A. C., Prevoo, D., & Swart, P. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.036 · Cited by 34
“The detection and quantification of steroid metabolites from various heterologous expression systems expressing steroidogenic cytochromes P450 are commonly preformed by thin layer chromatography (TLC) [3,4–7] and high-performance liquid chromatography (HPLC) [2,8,9].”
BackgroundWang, Y.-H., Tee, M. K., & Miller, W. L. (2010) · Endocrinology · doi:10.1210/en.2009-1247 · Cited by 31
“Wherever applicable, 10 pmol of cytochrome b5 was added to facilitate 17,20 lyase activity (9, 13).”
MethodSelf-citationEffect of Essential Oil Components on the Activity of Steroidogenic Cytochrome P450
Sharma, K., Lanzilotto, A., Yakubu, J., Therkelsen, S., Voegel, C. D., du Toit, T., Jørgensen, F. S., & Pandey, A. V. (2024) · Biomolecules · doi:10.3390/biom14020203 · Cited by 42
“To determine CYP17A1 hydroxylase activity, cells were treated with the [ 14 C]-Progesterone at a concentration of 10,000 cpm/1 µ M per well [22–24 , 54].”
MethodSelf-citationP450 Oxidoreductase Deficiency: A New Disorder of Steroidogenesis
Miller, W. L., Huang, N., Pandey, A. V., Flück, C. E., & Agrawal, V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1336.012 · Cited by 37
Self-citationModeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.001 · Cited by 31
Self-citationSteroid profiling of glucocorticoids in microdissected mouse brain across development
Hamden, J. E., Gray, K. M., Salehzadeh, M., Kachkovski, G. V., Forys, B. J., Ma, C., Austin, S. H., & Soma, K. K. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22808 · Cited by 33
“As mentioned previously, enzyme transcript levels might differ from protein levels, and steroidogenic enzymes are subject to post-translational modifications that rapidly affect enzyme activity (Pandey & Miller, 2005).”
BackgroundKim, D., Kim, V., McCarty, K. D., & Guengerich, F. P. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100571 · Cited by 31
High-Yield Expression of a Catalytically Active Membrane-Bound Protein: Human P450 Oxidoreductase
Sandee, D., & Miller, W. L. (2011) · Endocrinology · doi:10.1210/en.2011-0230 · Cited by 29
“Cytochrome b5 (20 pmol), which acts allostericly to facilitate the 17,20 lyase activity of P450c17 (15, 16) was added for 17,20 lyase assays.”
MethodSelf-citationMiller, W. L. (2012) · Science Signaling · doi:10.1126/scisignal.2003318 · Cited by 34
“This slide shows a computational model of the interaction of P450c17 (red) with POR (yellow) (13).”
BackgroundSelf-citationParween, S., Fernández-Cancio, M., Benito-Sanz, S., Camats, N., Rojas Velazquez, M. N., López-Siguero, J.-P., Udhane, S. S., Kagawa, N., Flück, C. E., Audí, L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa076 · Cited by 28
Self-citationThe Action of Cytochromeb5on CYP2E1 and CYP2C19 Activities Requires Anionic Residues D58 and D65
Peng, H., & Auchus, R. J. (2012) · Biochemistry · doi:10.1021/bi301384n · Cited by 28
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Self-citationZhu, W., Han, B., Fan, M., Wang, N., Wang, H., Zhu, H., Cheng, T., Zhao, S., Song, H., & Qiao, J. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.01.020 · Cited by 30
The Identification of Two CYP17 Alleles in the South African Angora Goat
Storbeck, K., Swart, A. C., Jt, S., & Swart, P. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701468649 · Cited by 28
“Furthermore, the 17,20 lyase activity of CYP17 is enhanced allosterically by cytochrome b5 and by post-translational phosphorylation (Pandey and Miller, 2005).”
BackgroundExpression of P450c17 in the Human Fetal Nervous System
Schonemann, M. D., Muench, M. O., Tee, M. K., Miller, W. L., & Mellon, S. H. (2012) · Endocrinology · doi:10.1210/en.2011-1545 · Cited by 28
Self-citationMultilevel regulation of steroid synthesis and metabolism in the bovine placenta
Nguyen, P. T., Conley, A. J., Soboleva, T. K., & Lee, R. S. F. (2011) · Molecular Reproduction and Development · doi:10.1002/mrd.22021 · Cited by 28
Steroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Self-citationNanoparticles with curcumin and piperine modulate steroid biosynthesis in prostate cancer
Yakubu, J., Natsaridis, E., du Toit, T., Barata, I. S., Tagit, O., & Pandey, A. V. (2025) · Scientific Reports · doi:10.1038/s41598-025-98102-z · Cited by 32
“CYB5 is required for 17,20 lyase activity of CYP17A1 for the conversion of 17-hydroxypregnenolone into DHEA 74 .”
InfluentialSelf-citationYang, L., Wu, Y., Su, Y., Zhang, X., Chakraborty, T., Wang, D., & Zhou, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1074921 · Cited by 27
“In mammalian species, a single Cyp17a was responsible for the catalyzation of the biosynthesis of C18, C19 and C21 steroids in both gonads and the adrenal gland (18, 38, 39).”
BackgroundKamrath, C., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.001 · Cited by 26
Jiang, S., Xu, S., Chen, H., Liu, X., Tang, Z., Cui, Y., & Liu, J. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.010 · Cited by 24
Wróbel, T. M., Rogova, O., Sharma, K., Velazquez, M. N. R., Pandey, A. V., Jørgensen, F. S., Arendrup, F. S., Andersen, K. L., & Björkling, F. (2022) · Biomolecules · doi:10.3390/biom12020165 · Cited by 25
Self-citationPatt, M., Beck, K. R., Marco, T. D., Jäger, M.-C., González‐Ruiz, V., Boccard, J., Rudaz, S. L., Hartmann, R. W., Salah, M., van Koppen, C. J., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113781 · Cited by 28
Shet, M. S., Fisher, C., Tremblay, Y., Bélanger, A., Conley, A. J., Mason, J. I., & Estabrook, R. W. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701468391 · Cited by 21
Troncoso, C., Cárcamo, J., Hedden, P., Tudzynski, B., & Rojas, M. C. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.08.026 · Cited by 23
“Multifunctional P450s have been described in glucocorticoid and sex steroid synthesis (Pandey and Miller, 2005), in the inactivation pathway of vitamin D (Prosser and Jones, 2004) and in cyanogenic glucoside biosynthesis (Sibbessen et al.”
Background
Metadata
- Authors
- Pandey, A. V., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Miller, Walter L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 280
- Issue
- 14
- Pages
- 13265-13271
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2030859870
- Semantic Scholar
- 1a3bf1c162de9cdde6333e2ac2e7f34414588b2c
- Cited by
- 165
- References
- 65
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 9 · 2023: 6 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 6 · 2013: 11 · 2012: 10
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5690 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Funders
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-41958, R01HD041958)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- P450c17, 17,20-lyase activity, cytochrome b5, serine phosphorylation, post-translational regulation, steroidogenesis, glucocorticoid synthesis, sex steroid synthesis, RNA interference, cytochrome P450 oxidoreductase, enzyme regulation
- MeSH terms
- Cell Line, Humans, 17-alpha-Hydroxypregnenolone, NADPH-Ferrihemoprotein Reductase, Phosphorylation, RNA, Serine, Steroid 17-alpha-Hydroxylase, Cytochromes b5, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.